Use Able AI chat for product recommendations

TNFSF8 Polyclonal antibody

TNFSF8 Polyclonal Antibody for IHC, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat

Applications

IHC, IF, ELISA

CD153, CD30 L, CD30 ligand, CD30L, CD30LG, TNFSF8

Formulation:  PBS, Azide, Glycerol
PBS, Azide, Glycerol
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 
SKU: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:

Able AI
Able AI
What's the best dilution for TNFSF8 in ?

Tested Applications

Positive IHC detected inhuman liver cancer tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

ApplicationDilution
Immunohistochemistry (IHC)IHC : 1:20-1:200
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

17852-1-AP targets TNFSF8 in IHC, IF, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen

CatNo: Ag12303

Product name: Recombinant human TNFSF8 protein

Source: e coli.-derived, PGEX-4T

Tag: GST

Domain: 61-234 aa of BC093630

Sequence: VVQRTDSIPNSPDNVPLKGGNCSEDLLCILKRAPFKKSWAYLQVAKHLNKTKLSWNKDGILHGVRYQDGNLVIQFPGLYFIICQLQFLVQCPNNSVDLKLELLINKHIKKQALVTVCESGMQTKHVYQNLSQFLLDYLQVNTTISVNVDTFQYIDTSTFPLENVLSIFLYSNSD

Predict reactive species
Full Name tumor necrosis factor (ligand) superfamily, member 8
Calculated Molecular Weight 234 aa, 26 kDa
Observed Molecular Weight 35-40 kDa
GenBank Accession NumberBC093630
Gene Symbol TNFSF8
Gene ID (NCBI) 944
RRIDAB_2878452
Conjugate Unconjugated
FormLiquid
Purification MethodAntigen affinity purification
UNIPROT IDP32971
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

TNFSF8, also named as CD30LG and CD153, is a member of the tumor necrosis factor (TNF) receptor superfamily, is a surface antigen used as a clinical marker for Hodgkin lymphoma and related hematologic malignancies. It induces proliferation of T-cells. CD30L enhanced the proliferation of CD3-activated T cells, but induced differential responses, including cell death, in several CD30-positive lymphoma-derived cell lines. For Glycosylation, the MW in WB detection is about 35-40 kDa.

Protocols

Product Specific Protocols
IHC protocol for TNFSF8 antibody 17852-1-APDownload protocol
WB protocol for TNFSF8 antibody 17852-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

What published studies show

The TNFSF8 Polyclonal antibody (Cat# 17852-1-AP) has 1 citation to date. It appears in the Asia Pacific Journal of Clinical Oncology (2026), in a study examining immune checkpoint activity and prognostic roles of TNFRSF8, CD160, and TNFSF9 in primary and brain-metastatic non-small cell lung cancer (NSCLC). The associated research field is oncology, specifically lung cancer immunology and immune checkpoint biology. The antibody was applied in immunofluorescence (IF) on human samples.

SpeciesApplicationTitle
humanIF

Asia Pac J Clin Oncol

Immune Checkpoint Activity and Prognostic Roles of TNFRSF8, CD160, and TNFSF9 in Primary and Brain Metastatic NSCLC.

Authors - Sun-Jiang Liu
Loading...
||
New chat

Able®

正在加载,请稍候...